Sunshine Healthcare has appointed Mr. T. Sayandhan as the Chief
Executive Officer of Lina Manufacturing, the pharmaceutical manufacturing segment of
the diversified company. Sayandhan, currently CEO of Sunshine Medical Devices, has
more than 30 years of experience in the healthcare industry. He joined Sunshine
Healthcare in 2017 to spearhead Sunshine Medical Devices and has been instrumental
in growing the healthcare business to be the key driver of the Group’s financial
performance, helping Sunshine Healthcare to sustain its growth over the few years
amidst tough macroeconomic conditions.
Commenting on the new appointment, Sunshine Healthcare Managing Director Shyam
Sathasivam said, “As a responsible Sri Lankan conglomerate, we believe the local
production of pharmaceuticals plays a vital role in maintaining the resilience of national
healthcare systems. When escalating macroeconomic conditions are putting immense
pressure on the local healthcare sector, producing pharmaceuticals locally will facilitate
access to needed medicines and decrease exposure to imports and international supply
chains. At this critical juncture, I believe Sayandhan has demonstrated the right
combination of talent and drive to step into this key leadership role at the company.”
Commenting on his appointment, Sayandhan said, “It is a challenging yet exciting time
to join Lina Manufacturing when the company is advancing its efforts to develop Sri
Lankan-made, innovative healthcare solutions. For over a decade, Lina manufacturing
has used its R&D acumen to develop pharmaceutical products for both the public and
private sectors. I am honored and look forward to leading the Lina team to further
diversify its locally produced pharmaceuticals portfolio and help widen access to quality
medicine to all Sri Lankans.”
Sayandhan started his career with GlaxoSmithKline, where he served for more than ten
years as a Medical Rep, Hospital Coordinator, Product Executive, Brand Manager and
Category Manager. He then took on an enhanced role at Hemas Pharmaceuticals,
serving as Country Manager for Allergan and Abbott Medical Optics. Before joining
Sunshine Healthcare, he was the Chief Executive Officer – Healthcare Cluster and
Director at Delmege Forsyth. Sayandhan, an Executive Committee Member of
Sunshine Holdings PLC, holds an MBA from the University of Peradeniya and is
currently reading for his doctorate. Sayandhan is also a Fellow of the Charted Institute
of Marketing (UK), Sri Lanka Institute of Marketing and the Institute of Management Sri
Lanka.
Press Release
Lina Manufacturing is Sri Lanka’s first Respiratory Care Research and Manufacturing
facility. It manufactures a range of respiratory pharmaceuticals and devices, including
Beclovent, Flutivent, Salbuvent, Prazolin, Winterpan and the award-winning Ventohaler
inhalers. Lina Spiro is the latest venture focusing on manufacturing the newest
technology, metered-dose inhalers (MDI) for respiratory care. It is the only such
manufacturer certified to WHO-GMP standards in Sri Lanka, opening doors to
international exports.
About Sunshine Healthcare
Sunshine Healthcare is Sri Lanka’s first fully integrated healthcare company from R&D
and manufacturing up to retailing of healthcare products, including last-mile distribution
across the country for all healthcare products. The company’s segments are Sunshine
Pharmaceuticals, Sunshine Medical Devices, Healthguard Pharmacy, Lina
Manufacturing and Healthguard Distribution. The company is a subsidiary of Sunshine
Holdings PLC, a publicly listed conglomerate contributing to ‘nation-building’ by creating
value in vital sectors of the Sri Lankan economy – mainly in the healthcare and
consumer sectors, with strategic investments in agribusiness.